- Beretta leaves Maryland over gun laws, heads for Tennessee
- Neal Boortz defends Hillary Clinton for representing child rapist
- House task force to recommend National Guard on border, faster deportations
- Top federal judge uses pizza to explain complex Obamacare situation
- Obama, Biden overhaul job training programs
- Drought-plagued Californians turn to paint to keep lawns green
- ISIL now forcing Iraqi shopkeepers to veil mannequins in Mosul
- 11 parents of Nigeria’s abducted girls die
- Genetic mapping triggers new hope on schizophrenia
- Turkish P.M. Erdogan won’t speak to Obama, but he’ll take calls from Biden
Latest FDA Items
Pfizer Inc. said Friday that the Food and Drug Administration will let the drugmaker apply for approval of its heavily touted experimental breast cancer medicine based on midstage patient testing results.
Federal health officials are lowering the starting dose of the popular sleeping aid drug Lunesta, due to risks of morning drowsiness that can impair driving ability and lead to injury.
A federal appeals court appeared poised Tuesday to continue blocking the nation's strictest restrictions on the use of abortion drugs, questioning the constitutionality of the Arizona rules a month after putting them on hold.
Genetically modified foods have been around for years, but most Americans have no idea if they are eating them.
U.S. Sen. Charles Schumer is asking the Food and Drug Administration to prevent a powdered alcohol from reaching store shelves this fall, saying that it would become "the Kool-Aid of teen binge drinking."
Federal health advisers have voted against a Merck proposal to sell its prescription respiratory pill Singulair as an over-the-counter allergy medication.
Former Canadian Prime Minister Pierre Trudeau once said, "There's no place for the state in the bedrooms of the nation."
Sleep deprived Americans have a new option to address hard-to-treat nighttime breathing problems: a first-of-kind device that keeps airways open by zapping them with an electrical current.
Federal health regulators are weighing the risks of permitting Merck to sell its prescription respiratory pill, Singulair, as an over-the-counter medicine for allergies.